Regeneron Pharmaceuticals, Inc. (REGN) Stock Price History
Historical prices from 2011 to 2026
Loading 10-year price history...
REGN Historical Performance
Short-Term Returns
REGN Stock Price Trajectory (2011–2026)
As of May 6, 2026, Regeneron Pharmaceuticals, Inc. (REGN) trades at $720.78, representing a +29.1% return over the past year. The stock has delivered a +46.5% total return over five years (+7.6% CAGR), reflecting significant long-term value creation.
The stock reached its all-time high of $1,211.20 on August 27, 2024. From this peak, REGN has corrected -40.5%, currently trading 5% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers BIIB (+63.2% 1Y), VRTX (-5.0% 1Y), and INCY (+67.5% 1Y), REGN has underperformed the peer group average. Compare REGN vs BIIB →
REGN Historical Price Data (2011–2026)
Showing 30 of 3,650 records| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-06 | 706.60 | 726.16 | 702.50 | 720.78 | 739K | +2.63% |
| 2026-05-05 | 710.73 | 715.62 | 699.23 | 702.33 | 293K | -1.01% |
| 2026-05-04 | 702.56 | 711.55 | 699.75 | 709.51 | 280K | +1.15% |
| 2026-05-01 | 703.02 | 714.48 | 700.26 | 701.42 | 700K | -0.80% |
| 2026-04-30 | 693.08 | 708.44 | 689.00 | 707.06 | 1.03M | +3.02% |
| 2026-04-29 | 705.11 | 708.80 | 668.85 | 686.36 | 1.83M | -6.21% |
| 2026-04-28 | 751.17 | 753.88 | 730.90 | 731.77 | 521K | -1.70% |
| 2026-04-27 | 745.47 | 756.40 | 743.61 | 744.44 | 579K | -0.95% |
| 2026-04-24 | 760.00 | 761.96 | 736.86 | 751.57 | 761K | -1.89% |
| 2026-04-23 | 750.99 | 767.23 | 747.26 | 766.02 | 926K | +2.60% |
| 2026-04-22 | 751.48 | 755.62 | 740.47 | 746.58 | 765K | -0.10% |
| 2026-04-21 | 746.01 | 751.54 | 734.12 | 747.36 | 572K | -0.31% |
| 2026-04-20 | 750.00 | 755.59 | 744.00 | 749.70 | 480K | -0.12% |
| 2026-04-17 | 754.74 | 758.61 | 746.91 | 750.57 | 485K | +0.61% |
| 2026-04-16 | 749.56 | 756.00 | 742.68 | 746.00 | 504K | -1.05% |
| 2026-04-15 | 758.67 | 760.58 | 739.12 | 753.93 | 556K | -0.21% |
| 2026-04-14 | 746.14 | 757.68 | 743.71 | 755.51 | 531K | +1.21% |
| 2026-04-13 | 747.74 | 756.90 | 737.34 | 746.46 | 737K | -0.32% |
| 2026-04-10 | 770.26 | 770.26 | 739.09 | 748.87 | 636K | -2.47% |
| 2026-04-09 | 767.12 | 772.45 | 761.50 | 767.85 | 554K | -0.99% |
| 2026-04-08 | 765.26 | 775.63 | 755.99 | 775.53 | 568K | +2.01% |
| 2026-04-07 | 758.40 | 761.91 | 747.85 | 760.27 | 620K | -0.36% |
| 2026-04-06 | 766.78 | 768.80 | 758.49 | 763.04 | 460K | +0.16% |
| 2026-04-02 | 767.23 | 770.11 | 745.00 | 761.85 | 987K | -1.98% |
| 2026-04-01 | 775.00 | 781.21 | 769.97 | 777.25 | 579K | +0.60% |
| 2026-03-31 | 755.80 | 774.26 | 755.80 | 772.64 | 611K | +3.12% |
| 2026-03-30 | 743.83 | 757.68 | 741.47 | 749.29 | 594K | +1.57% |
| 2026-03-27 | 755.40 | 759.47 | 736.66 | 737.71 | 489K | -2.51% |
| 2026-03-26 | 749.40 | 761.73 | 747.77 | 756.73 | 471K | +0.97% |
| 2026-03-25 | 744.67 | 757.98 | 744.02 | 749.47 | 470K | +1.05% |
Full REGN Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See REGN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs REGN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare REGN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonREGN — Frequently Asked Questions
Quick answers to the most common questions about buying REGN stock.
How has REGN stock performed recently?
REGN returned +29.1% over the past year, beating its 5-year annualized CAGR of +7.6%. The stock trades above its 200-day moving average, confirming the uptrend.
What is REGN's all-time high price?
Regeneron Pharmaceuticals, Inc. reached $1211.20 on 2024-08-27. The 52-week high is $821.11. Current 1-year return of +29.1% places the stock closer to historical peaks.
Where can I download REGN historical price data?
This page provides REGN daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2011-2026, downloadable in CSV format.